Biomaterials for intestinal organoid technology and personalized disease modeling
Source abstract
Abstract
Recent advances in intestinal organoid technologies have paved the way for in vitro recapitulation of the homeostatic renewal of adult tissues, tissue or organ morphogenesis during development, and pathogenesis of many disorders. In vitro modelling of individual patient diseases using organoid systems have been considered key in establishing rational design of personalized treatment strategies and in improving therapeutic outcomes. In addition, the transplantation of organoids into diseased tissues represents a novel approach to treat currently incurable diseases. Emerging evidence from intensive studies suggests that organoid systems' development and functional maturation depends on the presence of an extracellular matrix with suitable biophysical properties, where advanced synthetic hydrogels open new avenues for theoretical control of organoid phenotypes and potential applications of organoids in therapeutic purposes. In this review, we discuss the status, applications, challenges and perspectives of intestinal organoid systems emphasising on hydrogels and their properties suitable for intestinal organoid culture. We provide an overview of hydrogels used for intestinal organoid culture and key factors regulating their biological activity. The comparison of different hydrogels would be a theoretical basis for establishing design principles of synthetic niches directing intestinal cell fates and functions. STATEMENT OF SIGNIFICANCE: Intestinal organoid is an in vitro recapitulation of the gut, which self-organizes from intestinal stem cells and maintains many features of the native tissue. Since the development of this technology, intestinal organoid systems have made significant contribution to rapid progress in intestinal biology. Prevailing methodology for organoid culture, however, depends on animal-derived matrices and suffers from variability and potential risk for contamination of pathogens, limiting their therapeutic application. Synthetic scaffold matrices, hydrogels, might provide solutions to these issues and deepen our understanding on how intestinal cells sense and respond to key biophysical properties of the surrounding matrices. This review provides an overview of developing intestinal models and biomaterials, thereby leading to better understanding of current intestinal organoid systems for both biologists and materials scientists.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Cells and Metastasis · 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Enabling technologies for personalized and precision medicine10.1016/j.tibtech.2019.12.021 ↗
2. Personalized in vitro and in vivo cancer models to guide precision medicine10.1158/2159-8290.CD-16-1154 ↗
3. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer10.1038/nature05945 ↗
4. Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer10.1177/1758835919849753 ↗
5. Prospective derivation of a living organoid biobank of colorectal cancer patients10.1016/j.cell.2015.03.053 ↗
6. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence10.1136/gut.2006.117598 ↗
7. Identification of stem cells in small intestine and colon by marker gene Lgr510.1038/nature06196 ↗
8. Intestinal stem cell niche insights gathered from both in vivo and novel in vitro models
9. Intestinal stem cell niche: the extracellular matrix and cellular components
10. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
11. Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linking10.1186/s13036-019-0165-4 ↗
12. Functional diversity of laminins10.1146/annurev-cellbio-101011-155750 ↗
13. The extracellular matrix of the gastrointestinal tract: a regenerative medicine platform10.1038/nrgastro.2017.76 ↗
14. Remodelling the extracellular matrix in development and disease10.1038/nrm3904 ↗
15. Laminin alpha 5 influences the architecture of the mouse small intestine mucosa10.1242/jcs.025528 ↗
16. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche10.1038/nature07935 ↗
17. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche10.1038/nm.1951 ↗
18. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro10.1038/nature09691 ↗
19. Matrigel: a complex protein mixture required for optimal growth of cell culture10.1002/pmic.200900758 ↗
20. Synthetic alternatives to Matrigel10.1038/s41578-020-0199-8 ↗
21. Advances and current challenges in intestinal in vitro model engineering: a digest10.3389/fbioe.2019.00144 ↗
22. A monolayer of primary colonic epithelium generated on a scaffold with a gradient of stiffness for drug transport studies10.1021/acs.analchem.8b02845 ↗
23. Long-term renewable human intestinal epithelial stem cells as monolayers: a potential for clinical use10.1016/j.jpedsurg.2016.02.074 ↗
24. A practical guide to hydrogels for cell culture10.1038/nmeth.3839 ↗
25. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures
26. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition10.1016/j.stem.2018.11.016 ↗
27. Mini-gut organoids: reconstitution of the stem cell niche10.1146/annurev-cellbio-100814-125218 ↗
28. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium10.1053/j.gastro.2011.07.050 ↗
29. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro10.1038/nature09691 ↗
30. Generating human intestinal tissue from pluripotent stem cells in vitro10.1038/nprot.2011.410 ↗
31. Advances and current challenges in intestinal in vitro model engineering: a digest10.3389/fbioe.2019.00144 ↗
32. In vivo human PSC-derived intestinal organoids to study stem cell maintenance10.1007/978-1-0716-0747-3_12 ↗
33. Intestinal organoids generated from human pluripotent stem cells
34. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo
35. Gastrulation in the mouse embryo: ultrastructural and molecular aspects of germ layer morphogenesis10.1002/jemt.1070260405 ↗
36. Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation10.1038/361543a0 ↗
37. Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo10.1016/j.ydbio.2006.03.047 ↗
38. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning10.1242/dev.02413 ↗
39. Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo10.1038/nrm2618 ↗
40. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells10.1242/jcs.02553 ↗
41. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells
42. Pluripotency factors regulate definitive endoderm specification through eomesodermin10.1101/gad.607311 ↗
43. Development of definitive endoderm from embryonic stem cells in culture10.1242/dev.01044 ↗
44. Definitive endoderm of the mouse embryo: formation, cell fates, and morphogenetic function10.1002/dvdy.20846 ↗
45. Wnt signaling specifies and patterns intestinal endoderm10.1016/j.mod.2011.07.005 ↗
46. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx210.1016/j.devcel.2009.02.010 ↗
47. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice10.1073/pnas.96.13.7318 ↗
48. BMP signalling regulates anteroposterior endoderm patterning in zebrafish10.1016/S0925-4773(02)00252-6 ↗
49. FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo10.1016/j.mod.2005.10.001 ↗
50. Early mouse endoderm is patterned by soluble factors from adjacent germ layers10.1242/dev.127.8.1563 ↗
51. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system10.1038/nm.4233 ↗
52. Efficient and reproducible myogenic differentiation from human iPS Cells: prospects for modeling miyoshi myopathy in vitro10.1371/journal.pone.0061540 ↗
53. Genome editing in induced pluripotent stem cells using CRISPR/Cas910.1007/s12015-018-9811-3 ↗
54. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells10.1038/s41467-019-13916-6 ↗
55. iPSC-derived intestinal organoids from cystic fibrosis patients acquire CFTR activity upon TALEN-mediated repair of the p.F508del mutation10.1016/j.omtm.2020.04.005 ↗
56. Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells10.1371/journal.pone.0200657 ↗
57. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair10.1038/ncb3632 ↗
58. An in vivo model of human small intestine using pluripotent stem cells10.1038/nm.3737 ↗
59. Primary intestinal epithelial organoid culture10.1007/978-1-0716-0747-3_11 ↗
60. Intestinal enteroids/organoids: a novel platform for drug discovery in inflammatory bowel diseases10.3748/wjg.v25.i30.4125 ↗
61. Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids10.1007/s00535-018-01540-y ↗
62. Ordonez-Moran · 2020
63. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery10.1038/s41416-019-0672-6 ↗
64. Understanding cell-cell communication and signaling in the colorectal cancer microenvironment10.1002/ctm2.308 ↗
65. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning10.3389/fphar.2018.00006 ↗
66. Addressing patient specificity in the engineering of tumor models10.3389/fbioe.2019.00217 ↗
67. Reconstruction of the human colon epithelium in vivo10.1016/j.stem.2017.11.012 ↗
68. Organoid derivation and orthotopic xenotransplantation for studying human intestinal stem cell dynamics10.1007/978-1-0716-0747-3_21 ↗
69. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury10.1016/j.stem.2013.09.015 ↗
70. Engineered materials for organoid systems10.1038/s41578-019-0129-9 ↗
71. Intestinal tissue engineering: current concepts and future vision of regenerative medicine in the gut10.1111/j.1365-2982.2011.01843.x ↗
72. Bioengineering strategies to accelerate stem cell therapeutics10.1038/s41586-018-0089-z ↗
73. Cell-derived extracellular matrix for tissue engineering and regenerative medicine10.3389/fbioe.2020.602009 ↗
74. A step-by-step protocol for generating human fibroblast cell-derived completely biological extracellular matrix scaffolds10.1016/bs.mcb.2019.10.010 ↗
75. Human embryonic stem cells derived without feeder cells10.1016/S0140-6736(05)66473-2 ↗
76. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts10.1359/jbmr.070725 ↗
77. Hydrophilic cell-derived extracellular matrix as a niche to promote adhesion and differentiation of neural progenitor cells10.1039/C7RA08273H ↗
78. Murine Neural Stem Cell (NSC) Line, MEB5-derived decellularized matrix as an In Vitro extracellular matrix model in NSC niche10.1246/cl.180788 ↗
79. Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments10.1038/nmeth.2523 ↗
80. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals10.1016/j.stem.2008.09.002 ↗
81. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration10.1038/nature11826 ↗
82. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney10.1038/ncb2894 ↗
83. Organoid culture systems to study host–pathogen interactions10.1016/j.coi.2017.07.012 ↗
84. Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine10.1186/s40164-018-0122-9 ↗
85. Type I collagen as an extracellular matrix for the in vitro growth of human small intestinal epithelium10.1371/journal.pone.0107814 ↗
86. Use of collagen gel as an alternative extracellular matrix for the in vitro and in vivo growth of murine small intestinal epithelium10.1089/ten.tec.2012.0710 ↗
87. Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels10.1242/dev.143933 ↗
88. Development of collagen-based 3D matrix for gastrointestinal tract-derived organoid culture10.1155/2019/8472712 ↗
89. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis10.1038/s41586-020-2724-8 ↗
90. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture10.1038/s41467-019-13605-4 ↗
91. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration10.1016/j.biomaterials.2012.01.012 ↗
92. Matrigel: basement membrane matrix with biological activity10.1016/j.semcancer.2005.05.004 ↗
93. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components10.1016/0014-4827(92)90397-Q ↗
94. Designer matrices for intestinal stem cell and organoid culture10.1038/nature20168 ↗
95. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering10.1016/j.biomaterials.2010.02.044 ↗
96. Recent applications of polyethylene glycols (PEGs) and PEG derivatives10.4172/2329-6798.1000132 ↗
97. Chemical cross-linking methods for cell encapsulation in hydrogels
98. H.Md. Akil, Classification, processing and application of hydrogels: a review10.1016/j.msec.2015.07.053 ↗
99. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery10.1002/adma.201103574 ↗
100. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts10.1097/MIB.0b013e3182813297 ↗